日本全国调查:眼科诊疗中HTLV-1感染的应对现状
该研究对日本115家眼科机构进行问卷调查,69家(60.0%)回复。结果显示86.8%的机构在鉴别诊断葡萄膜炎时进行HTLV-1抗体检测,58.3%常规检测,67.6%有HAU诊疗经验,85.5%的机构HAU患者数未减少。结论认为日本眼科医生对HTLV-1感染的认识已成功推广。
要点
- 86.8%的机构在葡萄膜炎鉴别诊断中检测HTLV-1抗体,58.3%常规检测。
- 67.6%的机构有HTLV-1相关葡萄膜炎(HAU)诊疗经验。
- 85.5%的机构未观察到HAU患者数量减少。
核心结论
- 自HAU被确立为独立疾病实体的二十年来,日本多数眼科机构已在葡萄膜炎鉴别诊断中开展HTLV-1抗体检测。
- 调查数据表明向日本眼科医生提供HTLV-1感染相关信息的工作已成功实施。
研究设计与样本
- 对日本所有加入日本眼科学会的大学医院及所有加入日本眼炎症学会的地区核心机构进行问卷调查。
- 共调查115家机构,收到69家(60.0%)回复,汇总分析全国HAU诊疗现状数据。
主要发现
- HAU最常通过「血液检测联合特征性眼科表现」进行诊断。
- 86.8%的机构在葡萄膜炎诊疗中检测HTLV-1抗体,其中58.3%为常规检测。
- 67.6%的机构有HAU诊疗经验,85.5%的机构未发现HAU患者数量减少。
关键数值与推荐
- HAU最常基于血液检测和特征性眼科表现诊断。
- 86.8%的机构在葡萄膜炎鉴别诊断时进行HTLV-1抗体检测,58.3%常规检测。
- 67.6%的机构有HAU诊疗经验,85.5%的机构HAU患者数未见减少。
临床怎么用
- 在葡萄膜炎鉴别诊断中应检测HTLV-1抗体,尤其在HTLV-1流行区。
- 结合血液检测与特征性眼科表现诊断HAU。
局限性
- 调查回复率为60.0%(69/115家机构),可能存在无应答偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Japan is the most endemic of the developed nations in terms of human T-lymphotropic virus type 1 (HTLV-1) infection. Japan has been tackling HTLV-1 infection and has made remarkable progress. In ophthalmology, awareness of the association between HTLV-1 infection and uveitis has been increasing since the 1990s, when the relationship was first established. Here, we describe a nationwide survey and analysis of the current state of medical care for HTLV-1-associated uveitis (HAU) at ophthalmic facilities in Japan. METHODS: A questionnaire survey covered all university hospitals in Japan that were members of the Japanese Ophthalmological Society and all regional core facilities that were members of the Japanese Ocular Inflammation Society. Survey data were collected, and nationwide data on the state of medical care for HAU were tallied and analysed. RESULTS: Of the 115 facilities, 69 (60.0%) responded. HAU was most commonly diagnosed 'based on blood tests and characteristic ophthalmic findings'. Overall, 86.8% of facilities perform testing for HTLV-1 antibodies during medical care for diagnosing uveitis, with 58.3% routinely performing testing. Facilities with experience in providing medical care for HAU accounted for 67.6%. The survey also revealed that 85.5% of facilities had seen no decrease in the number of patients with HAU. CONCLUSIONS: In the two decades since the establishment of HAU as a pathological entity, the majority of facilities in Japan have started performing testing for HTLV-1 antibodies when considering differential diagnoses for uveitis. Our data suggest that providing information on HTLV-1 infection to ophthalmologists in Japan has been successfully implemented.
引用
- Kamoi K, Okayama A, Izumo S, et al. Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan. Br J Ophthalmol. 2020. PMID: 32152142. doi:10.1136/bjophthalmol-2019-315675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。